HUTCHMED secures priority review for sovleplenib NDA in China
Chiesi Group to acquire KalVista Pharmaceuticals for USD1.9bn in rare disease expansion strategy
Circio partners with USC to advance non-viral RNA delivery technologies
Cirius Therapeutics introduces gestational diabetes initiative
Vanda Pharmaceuticals reports publication of imsidolimab phase III findings in NEJM Evidence
GSK hepatitis B therapy bepirovirsen gains FDA priority review and breakthrough designation
Boehringer Ingelheim's survodutide phase 3 data show significant weight loss in obesity trial
Novartis secures European approval for remibrutinib in chronic spontaneous urticaria
GSK secures US and EU fast-track designations for efimosfermin in MASH
Shield Therapeutics announces Phase II trial initiation of ACCRUFeR in Japan for PAH
Veradermics reports positive Phase 2/3 results for oral VDPHL01 in pattern hair loss treatment
Thermo Fisher scientific agrees to sell microbiology business to Astorg